{"id":"NCT00677833","sponsor":"Pfizer","briefTitle":"Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa","officialTitle":"Phase 2/3, Open-Label, Comparative Trial Of Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In Children In Africa","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-06","primaryCompletion":"2010-09","completion":"2010-09","firstPosted":"2008-05-15","resultsPosted":"2014-06-26","lastUpdate":"2014-06-26"},"enrollment":361,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Malaria, Falciparum"],"interventions":[{"type":"DRUG","name":"Azithromycin plus Chloroquine","otherNames":[]},{"type":"DRUG","name":"Artemether-lumefantrine","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"The primary objective is to confirm the hypothesis that azithromycin used in combination with chloroquine is non-inferior to artemether- Lumefantrine for the treatment of symptomatic, uncomplicated malaria due to P. falciparum in children in African countries.","primaryOutcome":{"measure":"Percentage of Participants With Polymerase Chain Reaction (PCR)-Corrected Adequate Clinical and Parasitologic Response (ACPR) at Day 28 in the Modified Intent-to-treat (mITT) Population","timeFrame":"Day 28","effectByArm":[{"arm":"Cohort 2: Azithromycin + Chloroquine","deltaMin":89.27,"sd":null},{"arm":"Cohort 2: Artemether + Lumefantrine","deltaMin":98.37,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":16},"locations":{"siteCount":7,"countries":["Burkina Faso","Côte d’Ivoire","Ghana","Kenya","Mali"]},"refs":{"pmids":["25881046"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0661157&StudyName=Azithromycin%20Plus%20Chloroquine%20Versus%20Artemether-Lumefantrine%20For%20The%20Treatment%20Of%20Uncomplicated%20P.%20Falciparum%20Malaria%20In%20Children%20In%20Africa"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":55},"commonTop":["Infection parasitic","Vomiting","Malaria","Pyrexia","Cough"]}}